Bill Text: TX SB331 | 2011-2012 | 82nd Legislature | Enrolled


Bill Title: Relating to designating certain synthetic cannabinoids as controlled substances under the Texas Controlled Substances Act; providing penalties and establishing certain criminal consequences or procedures.

Spectrum: Slight Partisan Bill (Republican 13-7)

Status: (Passed) 2011-05-28 - Effective on 9/1/11 [SB331 Detail]

Download: Texas-2011-SB331-Enrolled.html
 
 
  S.B. No. 331
 
 
 
 
AN ACT
  relating to designating certain synthetic cannabinoids as
  controlled substances under the Texas Controlled Substances Act;
  providing penalties and establishing certain criminal consequences
  or procedures.
         BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF TEXAS:
         SECTION 1.  Subchapter D, Chapter 481, Health and Safety
  Code, is amended by adding Section 481.1031 to read as follows:
         Sec. 481.1031.  PENALTY GROUP 2-A. Penalty Group 2-A
  consists of any quantity of a synthetic chemical compound that is a
  cannabinoid receptor agonist and mimics the pharmacological effect
  of naturally occurring cannabinoids, including:
               naphthoylindoles structurally derived from
  3-(1-naphthoyl)indole by substitution at the nitrogen atom of the
  indole ring by alkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl,
  or 2-(4-morpholinyl)ethyl, whether or not further substituted in
  the indole ring to any extent, whether or not substituted in the
  napthyl ring to any extent, including:
                     AM-2201;
                     JWH-004;
                     JWH-007;
                     JWH-009;
                     JWH-015;
                     JWH-016;
                     JWH-018;
                     JWH-019;
                     JWH-020;
                     JWH-046;
                     JWH-047;
                     JWH-048;
                     JWH-049;
                     JWH-050;
                     JWH-073;
                     JWH-076;
                     JWH-079;
                     JWH-080;
                     JWH-081;
                     JWH-082;
                     JWH-083;
                     JWH-093;
                     JWH-094;
                     JWH-095;
                     JWH-096;
                     JWH-097;
                     JWH-098;
                     JWH-099;
                     JWH-100;
                     JWH-116;
                     JWH-122;
                     JWH-148;
                     JWH-149;
                     JWH-153;
                     JWH-159;
                     JWH-164;
                     JWH-165;
                     JWH-166;
                     JWH-180;
                     JWH-181;
                     JWH-182;
                     JWH-189;
                     JWH-193;
                     JWH-198;
                     JWH-200;
                     JWH-210;
                     JWH-211;
                     JWH-212;
                     JWH-213;
                     JWH-234;
                     JWH-235;
                     JWH-239;
                     JWH-240;
                     JWH-241;
                     JWH-242;
                     JWH-258;
                     JWH-259;
                     JWH-260;
                     JWH-262;
                     JWH-267;
                     JWH-386;
                     JWH-387;
                     JWH-394;
                     JWH-395;
                     JWH-397;
                     JWH-398;
                     JWH-399;
                     JWH-400;
                     JWH-412;
                     JWH-413; and
                     JWH-414;
               naphthylmethylindones structurally derived from
  1H-indol-3-yl-(1-naphthyl)methane by substitution at the nitrogen
  atom of the indole ring by alkyl, alkenyl, cycloalkylmethyl,
  cycloalkylethyl, or 2-(4-morpholinyl)ethyl, whether or not further
  substituted in the indole ring to any extent, whether or not
  substituted in the naphthyl ring to any extent, including:
                     JWH-175;
                     JWH-184;
                     JWH-185;
                     JWH-192;
                     JWH-194;
                     JWH-195;
                     JWH-196;
                     JWH-197; and
                     JWH-199;
               naphthoylpyrroles structurally derived from
  3-(1-naphthoyl)pyrrole by substitution at the nitrogen atom of the
  pyrrole ring by alkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl,
  or 2-(4-morpholinyl)ethyl, whether or not further substituted in
  the pyrrole ring to any extent, whether or not substituted in the
  naphthyl ring to any extent, including:
                     JWH-030;
                     JWH-145;
                     JWH-146;
                     JWH-147;
                     JWH-150;
                     JWH-156;
                     JWH-243;
                     JWH-244;
                     JWH-245;
                     JWH-246;
                     JWH-292;
                     JWH-293;
                     JWH-307;
                     JWH-308;
                     JWH-309;
                     JWH-346;
                     JWH-347;
                     JWH-348;
                     JWH-363;
                     JWH-364;
                     JWH-365;
                     JWH-366;
                     JWH-367;
                     JWH-368;
                     JWH-369;
                     JWH-370;
                     JWH-371;
                     JWH-372;
                     JWH-373; and
                     JWH-392;
               naphthylmethylindenes structurally derived from
  1-(1-naphthylmethyl)indene by substitution at the 3-position of
  the indene ring by alkyl, alkenyl, cycloalkylmethyl,
  cycloalkylethyl, or 2-(4-morpholinyl)ethyl, whether or not further
  substituted in the indene ring to any extent, whether or not
  substituted in the naphthyl ring to any extent, including:
                     JWH-171;
                     JWH-172;
                     JWH-173; and
                     JWH-176;
               phenylacetylindoles structurally derived from
  3-phenylacetylindole by substitution at the nitrogen atom of the
  indole ring with alkyl, alkenyl, cycloalkylmethyl,
  cycloalkylethyl, or 2-(4-morpholinyl)ethyl, whether or not further
  substituted in the indole ring to any extent, whether or not
  substituted in the phenyl ring to any extent, including:
                     AM-694;
                     AM-1241;
                     JWH-167;
                     JWH-203;
                     JWH-204;
                     JWH-205;
                     JWH-206;
                     JWH-208;
                     JWH-237;
                     JWH-248;
                     JWH-249;
                     JWH-250;
                     JWH-251;
                     JWH-252;
                     JWH-253;
                     JWH-302;
                     JWH-303;
                     JWH-305;
                     JWH-306;
                     JWH-311;
                     JWH-312;
                     JWH-313;
                     JWH-314; and
                     JWH-315;
               cyclohexylphenols structurally derived from
  2-(3-hydroxycyclohexyl)phenol by substitution at the 5-position of
  the phenolic ring by alkyl, alkenyl, cycloalkylmethyl,
  cycloalkylethyl, or 2-(4-morpholinyl)ethyl, whether or not
  substituted in the cyclohexyl ring to any extent, including:
                     CP-55,940;
                     CP-47,497;
                     analogues of CP-47,497, including VII, V, VIII, I,
  II, III, IV, IX, X, XI, XII, XIII, XV, and XVI;
                     JWH-337;
                     JWH-344;
                     JWH-345; and
                     JWH-405; and
               cannabinol derivatives, except where contained in
  marihuana, including tetrahydro derivatives of cannabinol and
  3-alkyl homologues of cannabinol or of its tetrahydro derivatives,
  such as:
                     Nabilone;
                     HU-210;
                     HU-211; and
                     WIN-55,212-2.
         SECTION 2.  Subsection (c), Section 481.111, Health and
  Safety Code, is amended to read as follows:
         (c)  A person does not violate Section 481.113, 481.116,
  481.1161, 481.121, or 481.125 if the person possesses or delivers
  tetrahydrocannabinols or their derivatives, or drug paraphernalia
  to be used to introduce tetrahydrocannabinols or their derivatives
  into the human body, for use in a federally approved therapeutic
  research program.
         SECTION 3.  The heading to Section 481.113, Health and
  Safety Code, is amended to read as follows:
         Sec. 481.113.  OFFENSE: MANUFACTURE OR DELIVERY OF
  SUBSTANCE IN PENALTY GROUP 2 OR 2-A.
         SECTION 4.  Subsection (a), Section 481.113, Health and
  Safety Code, is amended to read as follows:
         (a)  Except as authorized by this chapter, a person commits
  an offense if the person knowingly manufactures, delivers, or
  possesses with intent to deliver a controlled substance listed in
  Penalty Group 2 or 2-A.
         SECTION 5.  Subchapter D, Chapter 481, Health and Safety
  Code, is amended by adding Section 481.1161 to read as follows:
         Sec. 481.1161.  OFFENSE: POSSESSION OF SUBSTANCE IN PENALTY
  GROUP 2-A. (a)  Except as authorized by this chapter, a person
  commits an offense if the person knowingly possesses a controlled
  substance listed in Penalty Group 2-A, unless the person obtained
  the substance directly from or under a valid prescription or order
  of a practitioner acting in the course of professional practice.
         (b)  An offense under this section is:
               (1)  a Class B misdemeanor if the amount of the
  controlled substance possessed is, by aggregate weight, including
  adulterants or dilutants, two ounces or less;
               (2)  a Class A misdemeanor if the amount of the
  controlled substance possessed is, by aggregate weight, including
  adulterants or dilutants, four ounces or less but more than two
  ounces;
               (3)  a state jail felony if the amount of the controlled
  substance possessed is, by aggregate weight, including adulterants
  or dilutants, five pounds or less but more than four ounces;
               (4)  a felony of the third degree if the amount of the
  controlled substance possessed is, by aggregate weight, including
  adulterants or dilutants, 50 pounds or less but more than 5 pounds;
               (5)  a felony of the second degree if the amount of the
  controlled substance possessed is, by aggregate weight, including
  adulterants or dilutants, 2,000 pounds or less but more than 50
  pounds; and
               (6)  punishable by imprisonment in the Texas Department
  of Criminal Justice for life or for a term of not more than 99 years
  or less than 5 years, and a fine not to exceed $50,000, if the amount
  of the controlled substance possessed is, by aggregate weight,
  including adulterants or dilutants, more than 2,000 pounds.
         SECTION 6.  Subsections (c) and (d), Section 481.134, Health
  and Safety Code, are amended to read as follows:
         (c)  The minimum term of confinement or imprisonment for an
  offense otherwise punishable under Section 481.112(c), (d), (e), or
  (f), 481.113(c), (d), or (e), 481.114(c), (d), or (e),
  481.115(c)-(f), 481.116(c), (d), or (e), 481.1161(b)(4), (5), or
  (6), 481.117(c), (d), or (e), 481.118(c), (d), or (e),
  481.120(b)(4), (5), or (6), or 481.121(b)(4), (5), or (6) is
  increased by five years and the maximum fine for the offense is
  doubled if it is shown on the trial of the offense that the offense
  was committed:
               (1)  in, on, or within 1,000 feet of the premises of a
  school, the premises of a public or private youth center, or a
  playground; or
               (2)  on a school bus.
         (d)  An offense otherwise punishable under Section
  481.112(b), 481.113(b), 481.114(b), 481.115(b), 481.116(b),
  481.1161(b)(3), 481.120(b)(3), or 481.121(b)(3) is a felony of the
  third degree if it is shown on the trial of the offense that the
  offense was committed:
               (1)  in, on, or within 1,000 feet of any real property
  that is owned, rented, or leased to a school or school board, the
  premises of a public or private youth center, or a playground; or
               (2)  on a school bus.
         SECTION 7.  Subsection (d), Article 14.06, Code of Criminal
  Procedure, is amended to read as follows:
         (d)  Subsection (c) applies only to a person charged with
  committing an offense under:
               (1)  Section 481.121, Health and Safety Code, if the
  offense is punishable under Subsection (b)(1) or (2) of that
  section;
               (1-a)  Section 481.1161, Health and Safety Code, if the
  offense is punishable under Subsection (b)(1) or (2) of that
  section;
               (2)  Section 28.03, Penal Code, if the offense is
  punishable under Subsection (b)(2) of that section;
               (3)  Section 28.08, Penal Code, if the offense is
  punishable under Subsection (b)(1) of that section;
               (4)  Section 31.03, Penal Code, if the offense is
  punishable under Subsection (e)(2)(A) of that section;
               (5)  Section 31.04, Penal Code, if the offense is
  punishable under Subsection (e)(2) of that section;
               (6)  Section 38.114, Penal Code, if the offense is
  punishable as a Class B misdemeanor; or
               (7)  Section 521.457, Transportation Code.
         SECTION 8.  Subdivision (1), Subsection (a), Section 15,
  Article 42.12, Code of Criminal Procedure, is amended to read as
  follows:
               (1)  On conviction of a state jail felony under Section
  481.115(b), 481.1151(b)(1), 481.116(b), 481.1161(b)(3),
  481.121(b)(3), or 481.129(g)(1), Health and Safety Code, that is
  punished under Section 12.35(a), Penal Code, the judge shall
  suspend the imposition of the sentence and place the defendant on
  community supervision, unless the defendant has previously been
  convicted of a felony, other than a felony punished under Section
  12.44(a), Penal Code, or unless the conviction resulted from an
  adjudication of the guilt of a defendant previously placed on
  deferred adjudication community supervision for the offense, in
  which event the judge may suspend the imposition of the sentence and
  place the defendant on community supervision or may order the
  sentence to be executed.  The provisions of this subdivision
  requiring the judge to suspend the imposition of the sentence and
  place the defendant on community supervision do not apply to a
  defendant who:
                     (A)  under Section 481.1151(b)(1), Health and
  Safety Code, possessed more than five abuse units of the controlled
  substance;
                     (B)  under Section 481.1161(b)(3), Health and
  Safety Code, possessed more than one pound, by aggregate weight,
  including adulterants or dilutants, of the controlled substance; or
                     (C)  under Section 481.121(b)(3), Health and
  Safety Code, possessed more than one pound of marihuana.
         SECTION 9.  This Act takes effect September 1, 2011.
 
 
 
 
 
  ______________________________ ______________________________
     President of the Senate Speaker of the House     
 
         I hereby certify that S.B. No. 331 passed the Senate on
  March 30, 2011, by the following vote:  Yeas 31, Nays 0.
 
 
  ______________________________
  Secretary of the Senate    
 
         I hereby certify that S.B. No. 331 passed the House on
  May 13, 2011, by the following vote:  Yeas 138, Nays 0, one
  present not voting.
 
 
  ______________________________
  Chief Clerk of the House   
 
 
 
  Approved:
 
  ______________________________ 
              Date
 
 
  ______________________________ 
            Governor
feedback